C3.ai kept talking about hyperscaler alliances, federal contracts, and agentic platforms as the next big revenue engine, yet the scorecard that mattered to holders moved the other way. For C3.ai shareholders, the loss over the past year was 32.6%, including dividends. If you had been weighing a position back on 2 November 2025, knowing only the upbeat and cautious forecasts on record, which early cracks in the story would you have looked for?
On Simply Wall St, a Narrative is an investor's thesis written down: the reasoning, plus the numbers it rests on. Run those numbers and you get an estimated Fair Value.
This theme extends beyond C3.ai. See which of 39 AI small caps may still merit a closer look.
The shares cost US$17.58 at the start of the period, and C3.ai investors had to decide which of two stories felt more realistic.
On the bullish side, the Fair Value sat at US$25, based on revenue growth of 21.7% a year and profit margins rising to 12.7%. That narrative focused on hyperscaler partnerships and a new agentic platform to support high subscription growth.
The more cautious view put Fair Value at US$14.67 and assumed revenue would decline 2.7% a year even as margins moved toward 12.4%. That thesis emphasized partner dependence, sales execution issues, and uncertainty around future profitability.
Federal and defense bookings at C3.ai grew strongly, helped by projects tied to the Pentagon’s AI Acceleration Strategy and an expanded Shell agreement that pushed more predictive maintenance onto the agentic platform. That momentum sat beside pressure on the cautious case, yet the reported Q1 2027 revenue of US$52.4 million and ongoing losses left the profitability leg of the bullish story unproven. The evidence cut both ways.
The hinge assumption was not hype about partners but whether higher bookings would show up in the income statement. For any other stock pitched on hyperscaler alliances and federal pipelines, track booked contracts against later reported revenue and net margin to see if the promised operating leverage is actually appearing.
C3.ai now trades at US$11.55, after a 32.6% loss over the past year. The selected Narrative’s Fair Value sits above the current price and leans on a stronger federal, defense, and aerospace mix and heavier internal use of its own AI tools.
For the fall to look like an opening rather than a warning, a buyer today would need to believe C3.ai can turn public sector bookings and reported productivity gains into durable, subscription-heavy deployments that support a leaner cost base.
"The main thing that has to go right is that C3.ai converts public sector bookings momentum and reported internal AI-driven productivity gains into durable, value-based deployments that support a leaner cost base."
One Narrative disagrees with today's price. → See where this Narrative says C3.ai should trade
Passing on this one could have spared you a loss. Where might you find the opposite surprise? Start looking for companies whose prices leave room for a better outcome than investors expect. These three trade below our estimated value.
That is three of the list. See the full list of 34 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com